Navigation Links
Centocor Ortho Biotech Data to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
Date:5/28/2009

and Patient Instructions for Use.

About Trabectedin

Trabectedin is a novel cytotoxic antitumor agent that was originally derived from the Caribbean tunicate, Ecteinascidia turbinate ("sea squirt"). The compound is now produced synthetically. Trabectedin binds to the minor groove of DNA, interfering with cell division and genetic transcription processes and DNA repair machinery. Trabectedin is currently in Phase 3 development in ovarian cancer and to expand its uses in sarcoma.

According to the licensing agreement, PharmaMar SAU has rights to market the compound in Europe and Japan, while Centocor Ortho Biotech Products, L.P. has marketing rights for the product in the rest of the world.

About Centocor Ortho Biotech Products, L.P.

Centocor Ortho Biotech redefines the standard of care in immunology, nephrology, and oncology. The company was formed when Centocor, Inc. and Ortho Biotech Products, L.P. were consolidated in late 2008, and was renamed Centocor Ortho Biotech. Built upon a pioneering history, Centocor Ortho Biotech harnesses innovations in large-molecule and small-molecule research to create important new therapeutic options. Beyond its innovative medicines, Centocor Ortho Biotech is at the forefront of developing education and public policy initiatives to ensure patients and their families, caregivers, advocates, and healthcare professionals have access to the latest treatment information, support services, and quality care.

Note: This release corresponds to ASCO abstracts 5526, 5550, 5551, 8591 and 9625


'/>"/>
SOURCE Centocor Ortho Biotech Products, L.P.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
2. Centocor Announces Ustekinumab Biologic License Application Accepted for Filing by FDA
3. Centocor/Janssen-Cilags Ustekinumab Will Become the Gold Standard for Psoriasis By 2011
4. Centocor, Inc. and Schering-Plough Submit Application Requesting Approval of Golimumab in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
5. Ortho Biotech, L.P. and Centocor, Inc. Alert Authorized Distributors and Prescribing Physicians About Stolen Product
6. GeneNews provides Centocor access to its osteoarthritis program
7. Baseline Research Indicates High Interest in Centocor-Ortho Biotechs SIMPONI(R)
8. Ortho Biotech Supports FDA Advisory Committees Recommendations on Use of ESAs in Chronic Renal Failure Patients
9. Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases
10. New Orthopedic Surgical Robotics Company Opens Its Doors; Files with the FDA for Clearance of Its Flagship Product
11. Innovative Neurotronics, a Subsidiary of Hanger Orthopedic Group, Earns the 2007 da Vinci Award for the WalkAide System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/11/2014)... a one atom thick sheet of carbon, can be ... form of graphene that could have a significant impact ... paint, it could provide an ultra-strong, non-corrosive coating for ... oxide solutions can be used to paint various surfaces ... After a simple chemical treatment, the resulting coatings behave ...
(Date:9/11/2014)... 11, 2014 XBiotech announced today it has ... that the Company says will be used to dramatically ... is designed to fill, stopper and crimp vials, which ... the unit is said to contain an in-line feed ... a high level of quality compared to less sophisticated ...
(Date:9/11/2014)... 2014 The Registration Committee today ... now open for Pittcon 2015, the world’s largest ... event will be held March 8-12, 2015, at ... , The discounted registration fee of $175 ... 2/20/2015). This affordable price includes unlimited week-long access ...
(Date:9/11/2014)... (PRWEB) September 11, 2014 CollabRx, ... and IT systems that support clinical decision-making in ... Service that now supports the interpretation of copy ... a single, user-friendly report that contains clinically relevant ... toward cancer treatment planning and support of clinical ...
Breaking Biology Technology:Graphene paints a corrosion-free future 2Conferee Registration Opens for Pittcon 2015; Housing & Travel Open for Reservations 2CollabRx Launches Expansion of Its Genetic Variation Annotation Service to Support Copy Number Variation (CNV) Data 2CollabRx Launches Expansion of Its Genetic Variation Annotation Service to Support Copy Number Variation (CNV) Data 3
... -- ScinoPharm, an active,pharmaceutical ingredient (API) specialist, announced ... "Novel Crystal Forms of Irinotecan,Hydrochloride." The new patent ... processes for their preparation as well as,pharmaceutical compositions ... carcinoma of the colon or rectum using these ...
... Terumo Heart, Inc. is pleased to,announce the appointment ... (C.E.O.) and President, effective immediately. "With its innovative,mag-lev technology, ... in,the future treatment of heart failure. I am excited ... Pivotal trials in up to 40 clinical sites,and further ...
... 24 Imaging,Diagnostic Systems, Inc., (OTC Bulletin Board: IMDS) ... to announce the issuance of its,21st US Patent entitled ... of the Temporal Point Spread,Function of the Detected Light," ... (Logo: http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGO ) , ...
Cached Biology Technology:ScinoPharm Granted US Patent for Novel Crystal Forms 2Terumo Heart Announces Appointment of William Pinon to Chief Executive Officer and President 2Imaging Diagnostic Systems is Recognized for Its Advanced Engineering in Time-Resolved Techniques by the US Patent Office 2Imaging Diagnostic Systems is Recognized for Its Advanced Engineering in Time-Resolved Techniques by the US Patent Office 3
(Date:9/12/2014)... origin and condition of extraction of type I collagen ... radii of their circular circular cross sections stay distributed ... for the most part of them. Jean Charvolin and ... the Paris-Sud University propose therefore that, once the growth ... factors, their lateral size be limited by internal physical ...
(Date:9/12/2014)... on the way to dealing with climate change: ... worth of previously unreachable oil and natural gas ... and benefits from "fracking," which requires blasting ... into underground rock formations, are the subject of ... government databases. The survey covers not only greenhouse ...
(Date:9/12/2014)... POINT ROBERTS, Washington , September 12, 2014 ... global news source covering leading sectors including biometrics and mobile ... 9 th launch of Apple Pay, its new payment ... Kephart , founder of the Secure Identity and Biometrics Association ... (NASDAQ: NXTD ) a company that is introducing ...
Breaking Biology News(10 mins):Conjecture on the lateral growth of Type I collagen fibrils 2Stanford-led study assesses the environmental costs and benefits of fracking 2Stanford-led study assesses the environmental costs and benefits of fracking 3Stanford-led study assesses the environmental costs and benefits of fracking 4Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service 2Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service 3Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service 4Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service 5
... and colleagues have identified a novel retroviral resistance gene, called ... virus, as well as HIV-1, in cell culture. The researchers ... specific laboratory rat cell line caused a significant block to ... and synthesize the viral DNA, but were excluded from entering ...
... Xcytrin, manufactured by Pharmacyclics, Inc.) works to thwart cancer ... according to a team of researchers led by Joseph ... at the Keck School of Medicine of the University ... increases in the amount of zinc available inside the ...
... conducted in monkeys at the Oregon National Primate Research ... of vitamin C may have potential to counteract some ... may benefit thousands of babies born to mothers who ... research is published in the current edition of the ...
Cached Biology News:USC researchers determine mechanism of action of chemotherapy drug 2OHSU research shows vitamin C counteracts some negative impacts of smoking on unborn babies 2OHSU research shows vitamin C counteracts some negative impacts of smoking on unborn babies 3
... expression of an N-terminal FLAG® fusion and ... marker from bicistronic mRNA. Two genes ... for transcription of a single message from ... for protein-protein interaction studies, multi-subunit proteins, and ...
Mouse monoclonal antibody raised against a partial recombinant PRG4. NCBI Entrez Gene ID = PRG4...
Mouse monoclonal antibody raised against a partial recombinant FAAH. NCBI Entrez Gene ID = FAAH...
Mouse monoclonal antibody raised against a partial recombinant ZNF167. NCBI Entrez Gene ID = ZNF167...
Biology Products: